Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype

被引:380
作者
Growney, JD
Shigematsu, H
Li, Z
Lee, BH
Adeisperger, J
Rowan, R
Curley, DP
Kutok, JL
Akashi, K
Williams, IR
Speck, NA
Gilliland, DG
机构
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[5] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH USA
[6] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
关键词
D O I
10.1182/blood-2004-08-3280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Homozygous loss of function of Runx1 (Runt-related transcription factor 1 gene) during murine development results in an embryonic lethal phenotype characterized by a complete lack of definitive hematopoiesis. In light of recent reports of disparate requirements for hematopoietic transcription factors during development as opposed to adult hematopoiesis, we used a conditional gene-targeting strategy to effect the loss of Runx1 function in adult mice. in contrast with the critical role of Runx1 during development, Runx1 was not essential for hematopoiesis in the adult hematopoietic compartment, though a number of significant hematopoietic abnormalities were observed. Runx1 excision had lineage-specific effects on B- and T-cell maturation and pronounced inhibition of common lymphocyte progenitor production. Runx1 excision also resulted in inefficient platelet production. Of note, Runx1-deficient mice developed a mild myeloproliferative phenotype characterized by an increase in peripheral blood neutrophils, an increase in myeloid progenitor populations, and extramedullary hematopoiesis composed of maturing myeloid and erythroid elements. These findings indicate that Runx1 deficiency has markedly different consequences during development compared with adult hematopoiesis, and they provide insight into the phenotypic manifestations of Runx1 deficiency in hematopoietic malignancies.
引用
收藏
页码:494 / 504
页数:11
相关论文
共 63 条
  • [1] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
    Akashi, K
    Traver, D
    Miyamoto, T
    Weissman, IL
    [J]. NATURE, 2000, 404 (6774) : 193 - 197
  • [2] Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
    Borkhardt, A
    Cazzaniga, G
    Viehmann, S
    Valsecchi, MG
    Ludwig, WD
    Burci, L
    Mangioni, S
    Schrappe, M
    Riehm, H
    Lampert, F
    Basso, G
    Masera, G
    Harbott, J
    Biondi, A
    [J]. BLOOD, 1997, 90 (02) : 571 - 577
  • [3] Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo
    Cai, ZL
    de Bruijn, M
    Ma, XQ
    Dortland, B
    Luteijn, T
    Downing, JR
    Dzierzak, E
    [J]. IMMUNITY, 2000, 13 (04) : 423 - 431
  • [4] IDENTIFICATION OF A CRITICAL REGULATORY SITE IN THE HUMAN INTERLEUKIN-3 PROMOTER BY IN-VIVO FOOTPRINTING
    CAMERON, S
    TAYLOR, DS
    TEPAS, EC
    SPECK, NA
    MATHEYPREVOT, B
    [J]. BLOOD, 1994, 83 (10) : 2851 - 2859
  • [5] Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11
    Castilla, LH
    Wijmenga, C
    Wang, Q
    Stacy, T
    Speck, NA
    Eckhaus, M
    MarinPadilla, M
    Collins, FS
    WynshawBoris, A
    Liu, PP
    [J]. CELL, 1996, 87 (04) : 687 - 696
  • [6] SCL is required for normal function of short-term repopulating hematopoietic stem cells
    Curtis, DJ
    Hall, MA
    Van Stekelenburg, LJ
    Robb, L
    Jane, SM
    Begley, CG
    [J]. BLOOD, 2004, 103 (09) : 3342 - 3348
  • [7] Core-binding factors in hematopoiesis and immune function
    de Bruijn, MFTR
    Speck, NA
    [J]. ONCOGENE, 2004, 23 (24) : 4238 - 4248
  • [8] RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
    Elagib, KE
    Racke, FK
    Mogass, M
    Khetawat, R
    Delehanty, LL
    Goldfarb, AN
    [J]. BLOOD, 2003, 101 (11) : 4333 - 4341
  • [9] ERICKSON P, 1992, BLOOD, V80, P1825
  • [10] Fenrick R, 1999, MOL CELL BIOL, V19, P6566